Mustang Bio (MBIO) Asset Utilization Ratio (2018 - 2019)
Mustang Bio (MBIO) posted quarterly Asset Utilization Ratio of 0.0 for Q2 2019, down 18.41% year-over-year from 0.0 in Q2 2018, and down 26.5% quarter-over-quarter from 0.0 in Q3 2018.
Mustang Bio (MBIO) Asset Utilization Ratio (2018 - 2019) Analysis & Trends
Mustang Bio (MBIO) has reported Asset Utilization Ratio for 2 consecutive years, with 0.0 the latest figure, recorded in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 0.13 |
| 10 | Mustang Bio | 3.90 Mn | 3.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 0.00 |
| Sep 30, 2018 | 0.00 |
| Jun 30, 2018 | 0.00 |
| Mar 31, 2018 | 0.00 |